|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.99 USD | -0.81% |
|
+33.52% | +47.29% |
| May. 02 | NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue | MT |
| May. 02 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
NovoCure Limited reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 138.5 million compared to USD 122.18 million a year ago. Net loss was USD 38.76 million compared to USD 53.06 million a year ago.
Basic loss per share from continuing operations was USD 0.36 compared to USD 0.5 a year ago. Diluted loss per share from continuing operations was USD 0.36 compared to USD 0.5 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +47.29% | 2.37B | |
| +73.24% | 12.39B | |
| -19.09% | 7.89B | |
| +5.88% | 6.59B | |
| +13.24% | 5.43B | |
| +38.48% | 4.96B | |
| -17.30% | 4.72B | |
| -19.78% | 4.02B | |
| -29.53% | 2.66B | |
| -2.10% | 1.96B |
NOVOCURE LIMITED 
